LSL Pharma Group (TSXV:LSL) EV-to-Revenue : 7.01 (As of May. 26, 2024)

View and export this data going back to 2023. Start your Free Trial

What is LSL Pharma Group EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, LSL Pharma Group's enterprise value is C$70.26 Mil. LSL Pharma Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was C$10.03 Mil. Therefore, LSL Pharma Group's EV-to-Revenue for today is 7.01.

The historical rank and industry rank for LSL Pharma Group's EV-to-Revenue or its related term are showing as below:

TSXV:LSL' s EV-to-Revenue Range Over the Past 10 Years
Min: 4.89 Med: 5.57 Max: 10.82
Current: 7.01

During the past 4 years, the highest EV-to-Revenue of LSL Pharma Group was 10.82. The lowest was 4.89. And the median was 5.57.

TSXV:LSL's EV-to-Revenue is ranked worse than
83.59% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 2.285 vs TSXV:LSL: 7.01

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-26), LSL Pharma Group's stock price is C$0.50. LSL Pharma Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.13. Therefore, LSL Pharma Group's PS Ratio for today is 3.97.

LSL Pharma Group EV-to-Revenue Historical Data

The historical data trend for LSL Pharma Group's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LSL Pharma Group EV-to-Revenue Chart

LSL Pharma Group Annual Data

Trend

Sep20

Dec21

Dec22

Dec23

EV-to-Revenue

5.61

LSL Pharma Group Quarterly Data
	Sep20	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial							-	8.32	5.09	6.03	5.61

Competitive Comparison of LSL Pharma Group's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, LSL Pharma Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LSL Pharma Group's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, LSL Pharma Group's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where LSL Pharma Group's EV-to-Revenue falls into.

LSL Pharma Group EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

LSL Pharma Group's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	70.264	/	10.028
	=	7.01

LSL Pharma Group's current Enterprise Value is C$70.26 Mil.
LSL Pharma Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$10.03 Mil.

LSL Pharma Group (TSXV:LSL) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

LSL Pharma Group's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.50	/	0.126
	=	3.97

LSL Pharma Group's share price for today is C$0.50.
LSL Pharma Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.13.

LSL Pharma Group EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of LSL Pharma Group's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

LSL Pharma Group (TSXV:LSL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » LSL Pharma Group Inc (TSXV:LSL) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

3030, Le Carrefour Boulevard, Suite 1002, Laval, QC, CAN, H7T 2P5

Website

LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.

LSL Pharma Group (TSXV:LSL) Headlines

No Headlines